{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:22:47Z","timestamp":1791595367968,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5529-0","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T09:02:51Z","timestamp":1554454971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0901-5252","authenticated-orcid":false,"given":"R-M","family":"Amini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Enblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Laszlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ayoola Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Loskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Th\u00f6rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"issue":"21","key":"5529_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease. N Engl J Med. 1998;339(21):1506\u201314. Epub 1998\/11\/20.","journal-title":"N Engl J Med"},{"issue":"3","key":"5529_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000094678","volume":"116","author":"S Barath","year":"2006","unstructured":"Barath S, Aleksza M, Keresztes K, Toth J, Sipka S, Szegedi G, et al. Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma. Acta Haematol. 2006;116(3):181\u20135 Epub 2006\/10\/04.","journal-title":"Acta Haematol"},{"issue":"3","key":"5529_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1634\/theoncologist.2015-0251","volume":"21","author":"TP Vassilakopoulos","year":"2016","unstructured":"Vassilakopoulos TP, Dimopoulou MN, Angelopoulou MK, Petevi K, Pangalis GA, Moschogiannis M, et al. Prognostic implication of the absolute lymphocyte to absolute monocyte count ratio in patients with classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and Dacarbazine or equivalent regimens. Oncologist. 2016;21(3):343\u201353. Epub 2016\/02\/28.","journal-title":"Oncologist"},{"issue":"6","key":"5529_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.mayocp.2015.03.025","volume":"90","author":"T Tadmor","year":"2015","unstructured":"Tadmor T, Bari A, Marcheselli L, Sacchi S, Aviv A, Baldini L, et al. Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: evaluation based on data from 1450 patients. Mayo Clin Proc. 2015;90(6):756\u201364. Epub 2015\/06\/06.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"5529_CR5","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3109\/10428194.2015.1014367","volume":"56","author":"B Lin","year":"2015","unstructured":"Lin B, Chen C, Qian Y, Feng J. Prognostic role of peripheral blood lymphocyte\/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis. Leuk Lymphoma. 2015;56(9):2563\u20138. Epub 2015\/02\/18.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5529_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.clml.2014.10.001","volume":"15","author":"A Belotti","year":"2015","unstructured":"Belotti A, Doni E, Bolis S, Rossini F, Casaroli I, Pezzatti S, et al. Peripheral blood lymphocyte\/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era. Clin Lymphoma, Myeloma Leuk. 2015;15(4):208\u201313. Epub 2014\/12\/04.","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"key":"5529_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","volume":"107","author":"D Mougiakakos","year":"2010","unstructured":"Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer. Adv Cancer Res. 2010;107:57\u2013117 Epub 2010\/04\/20.","journal-title":"Adv Cancer Res"},{"issue":"6","key":"5529_CR8","first-page":"7957","volume":"14","author":"I Hus","year":"2017","unstructured":"Hus I, Bojarska-Junak A, Kaminska M, Dobrzynska-Rutkowska A, Szatan K, Szymczyk A, et al. Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma. Oncol Lett. 2017;14(6):7957\u201364. Epub 2017\/12\/19.","journal-title":"Oncol Lett"},{"issue":"5","key":"5529_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/cyto.b.21330","volume":"90","author":"E Gunduz","year":"2016","unstructured":"Gunduz E, Sermet S, Musmul A. Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients. Cytometry B Clin Cytom. 2016;90(5):449\u201354 Epub 2015\/10\/08.","journal-title":"Cytometry B Clin Cytom"},{"key":"5529_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6:e1792 Epub 2015\/06\/19.","journal-title":"Cell Death Dis"},{"key":"5529_CR11","doi-asserted-by":"crossref","unstructured":"Vari F, Arpon D, Keane C, Hertzberg MS, Talaulikar D, Jain S, et al. Immune evasion via PD-1\/PD-L1 on NK-cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood. 2018;131(16):1809\u201319 Epub 2018\/02\/17.","DOI":"10.1182\/blood-2017-07-796342"},{"key":"5529_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-065X.2006.00462.x","volume":"214","author":"P Parham","year":"2006","unstructured":"Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev. 2006;214:155\u201360 Epub 2006\/11\/15.","journal-title":"Immunol Rev"},{"issue":"7","key":"5529_CR13","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, et al. Human CD56bright NK cells: an update. J Immunol. 2016;196(7):2923\u201331 Epub 2016\/03\/20.","journal-title":"J Immunol"},{"issue":"11","key":"5529_CR14","doi-asserted-by":"publisher","first-page":"e1055993","DOI":"10.1080\/2162402X.2015.1055993","volume":"4","author":"S Kloss","year":"2015","unstructured":"Kloss S, Chambron N, Gardlowski T, Arseniev L, Koch J, Esser R, et al. Increased sMICA and TGFbeta1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells. Oncoimmunology. 2015;4(11):e1055993 Epub 2015\/10\/10.","journal-title":"Oncoimmunology."},{"issue":"5","key":"5529_CR15","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.4049\/jimmunol.1200140","volume":"190","author":"E Mamessier","year":"2013","unstructured":"Mamessier E, Pradel LC, Thibult ML, Drevet C, Zouine A, Jacquemier J, et al. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets. J Immunol. 2013;190(5):2424\u201336 Epub 2013\/01\/30.","journal-title":"J Immunol"},{"issue":"3","key":"5529_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162\u201374. Epub 2009\/02\/07.","journal-title":"Nat Rev Immunol"},{"key":"5529_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150. Epub 2016\/07\/07.","journal-title":"Nat Commun"},{"key":"5529_CR18","doi-asserted-by":"crossref","unstructured":"Betsch A, Rutgeerts O, Fevery S, Sprangers B, Verhoef G, Dierickx D, et al. Myeloid-derived suppressor cells in lymphoma: the good, the bad and the ugly. Blood Rev. 2018; Epub 2018\/04\/25.","DOI":"10.1016\/j.blre.2018.04.006"},{"issue":"1","key":"5529_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12967-016-1037-z","volume":"14","author":"E Eriksson","year":"2016","unstructured":"Eriksson E, Wenthe J, Irenaeus S, Loskog A, Ullenhag G. Gemcitabine reduces MDSCs, tregs and TGFbeta-1 while restoring the teff\/treg ratio in patients with pancreatic cancer. J Transl Med. 2016;14(1):282 Epub 2016\/10\/01.","journal-title":"J Transl Med"},{"key":"5529_CR20","doi-asserted-by":"crossref","unstructured":"Manson G, Houot R. Next generation immunotherapies for lymphoma: one foot in the future. Ann Oncol. 2018;29(3):588\u2013601 Epub 2018\/01\/25.","DOI":"10.1093\/annonc\/mdy032"},{"issue":"2","key":"5529_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/0284186X.2017.1337926","volume":"57","author":"B Glimelius","year":"2018","unstructured":"Glimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlstrom H, et al. U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. Acta Oncol. 2018;57(2):187\u201394 Epub 2017\/06\/21.","journal-title":"Acta Oncol"},{"key":"5529_CR22","unstructured":"Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues: WHO\/IARC; 2016."},{"issue":"4","key":"5529_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-0142(19910815)68:4<768::AID-CNCR2820680418>3.0.CO;2-1","volume":"68","author":"O Tullgren","year":"1991","unstructured":"Tullgren O, Grimfors G, Holm G, Johansson B, Svedmyr E, Wedelin C, et al. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up. Cancer. 1991;68(4):768\u201375 Epub 1991\/08\/15.","journal-title":"Cancer."},{"key":"5529_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-4933-3-10","volume":"3","author":"SM Chidrawar","year":"2006","unstructured":"Chidrawar SM, Khan N, Chan YL, Nayak L, Moss PA. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun Ageing. 2006;3:10 Epub 2006\/12\/01.","journal-title":"Immun Ageing"},{"issue":"4","key":"5529_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000328005","volume":"3","author":"I Gayoso","year":"2011","unstructured":"Gayoso I, Sanchez-Correa B, Campos C, Alonso C, Pera A, Casado JG, et al. Immunosenescence of human natural killer cells. J Innate Immun. 2011;3(4):337\u201343 Epub 2011\/05\/18.","journal-title":"J Innate Immun"},{"key":"5529_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/nyas.12469","volume":"1319","author":"S Solito","year":"2014","unstructured":"Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci. 2014;1319:47\u201365 Epub 2014\/06\/27.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"5529_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00262-015-1782-5","volume":"65","author":"S Mandruzzato","year":"2016","unstructured":"Mandruzzato S, Brandau S, Britten CM, Bronte V, Damuzzo V, Gouttefangeas C, et al. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study. Cancer Immunol, Immunother. 2016;65(2):161\u20139. Epub 2016\/01\/06.","journal-title":"Cancer Immunol, Immunother"},{"issue":"2","key":"5529_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cytob.21206","volume":"88","author":"V Damuzzo","year":"2015","unstructured":"Damuzzo V, Pinton L, Desantis G, Solito S, Marigo I, Bronte V, et al. Complexity and challenges in defining myeloid-derived suppressor cells. Cytometry B Clin Cytom. 2015;88(2):77\u201391. Epub 2014\/12\/17.","journal-title":"Cytometry B Clin Cytom"},{"key":"5529_CR29","doi-asserted-by":"crossref","unstructured":"Gorczyca W. Flow cytometry in neoplastic hematology morphologic-Immunophenotypic correlation: Informa Health Care; 2017.","DOI":"10.1201\/9781315113715"},{"issue":"7","key":"5529_CR30","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1128\/CVI.05715-11","volume":"19","author":"L Zhou","year":"2012","unstructured":"Zhou L, Somasundaram R, Nederhof RF, Dijkstra G, Faber KN, Peppelenbosch MP, et al. Impact of human granulocyte and monocyte isolation procedures on functional studies. Clin Vaccine Immunol. 2012;19(7):1065\u201374. Epub 2012\/05\/04.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"5529_CR31","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00262-017-2036-5","volume":"66","author":"M Roussel","year":"2017","unstructured":"Roussel M, Irish JM, Menard C, Lhomme F, Tarte K, Fest T. Regulatory myeloid cells: an underexplored continent in B-cell lymphomas. Cancer Immunol, Immunother. 2017;66(8):1103\u201311. Epub 2017\/07\/10.","journal-title":"Cancer Immunol, Immunother"},{"issue":"56","key":"5529_CR32","doi-asserted-by":"publisher","first-page":"95083","DOI":"10.18632\/oncotarget.18297","volume":"8","author":"H Shoji","year":"2017","unstructured":"Shoji H, Tada K, Kitano S, Nishimura T, Shimada Y, Nagashima K, et al. The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy. Oncotarget. 2017;8(56):95083\u201394 Epub 2017\/12\/10.","journal-title":"Oncotarget."},{"issue":"2","key":"5529_CR33","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3892\/ol.2017.6305","volume":"14","author":"K Gonda","year":"2017","unstructured":"Gonda K, Shibata M, Ohtake T, Matsumoto Y, Tachibana K, Abe N, et al. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncol Lett. 2017;14(2):1766\u201374. Epub 2017\/08\/10.","journal-title":"Oncol Lett"},{"issue":"19","key":"5529_CR34","doi-asserted-by":"publisher","first-page":"27676","DOI":"10.18632\/oncotarget.8507","volume":"7","author":"O Marini","year":"2016","unstructured":"Marini O, Spina C, Mimiola E, Cassaro A, Malerba G, Todeschini G, et al. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget. 2016;7(19):27676\u201388. Epub 2016\/04\/07.","journal-title":"Oncotarget."},{"issue":"9\u201310","key":"5529_CR35","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1080\/0284186X.2016.1189093","volume":"55","author":"M Abdulla","year":"2016","unstructured":"Abdulla M, Laszlo S, Triumf J, Hedstrom G, Berglund M, Enblad G, et al. A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients. Acta Oncol. 2016;55(9\u201310):1126\u201331. Epub 2016\/08\/24.","journal-title":"Acta Oncol"},{"issue":"1","key":"5529_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/ejh.12987","volume":"100","author":"P Hollander","year":"2018","unstructured":"Hollander P, Rostgaard K, Smedby KE, Molin D, Loskog A, de Nully Brown P, et al. An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome. Eur J Haematol. 2018;100(1):88\u201397. Epub 2017\/10\/25.","journal-title":"Eur J Haematol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5529-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5529-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5529-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T23:07:54Z","timestamp":1585955274000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5529-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5529"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5529-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and written informed consent has been obtained from each patient. The study was approved by the Regional Ethical Committee in Uppsala (Dnr 2010\/198 and Dnr 2013\/059).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"316"}}